SAN FRANCISCO, May 30, 2012 /PRNewswire/ -- Nektar Therapeutics' (Nasdaq: NKTR) President and Chief Executive Officer, Howard W.

CAMBRIDGE, England, May 28, 2012 /PRNewswire/ -- Acacia Pharma announces positive results from its Phase II study of APD421, in the prevention of post-operative nausea

Chewing fresh gum, thinking happy thoughts, taking deep breaths—they’re all ways we try and mentally distract ourselves from pain. New research shows there may be some truth behind these kooky pain-relieving tactics.

Mental distractions make pain easier to take, and those pain-relieving effects aren't just in your head.

RALEIGH, N.C., May 9, 2012 /PRNewswire/ -- BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced that Dr. Mark A.